Therefore, this study aims to investigate the Ki-67 labeling index, SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 polymorphisms, serum SSTR2, SSTR5, and AIP levels, and their association with the development of pituitary adenomas. This evidence concerns the gene SSTR2 and pituitary gland adenoma.